Beau Harger discusses some of the opportunities that pharmacy compounders have to help patients struggling with seasonal health challenges.

Matt Martin of PCCA Clinical Services and Melissa Merrell Rhoads, Director of Formulation development discuss two possible alternatives to Dichloralphenazone for compounding pharmacists.

Lip balms provide necessary protection against environmental factors. Fabiana Banov, one of PCCA's Senior Formulation Pharmacists, discusses how compounding pharmacists can flavor lip balms to make them more palatable for patients.

Tricia Heitman of PCCA's Clinical Services Team discusses compounded treatment options for women suffering from atropic vaginitis, vluvar lichen sclerosis, desquamative inflammatory vaginitis, vaginismus, high-tone pelvic floor dysfunction and vulvodynia.

Courtaney Davis and Stacey Lemus, both PCCA formulation specialists discuss the best practices to consider when selecting a gelling agent for your compounded preparation.

Maria Carvalho discusses the latest versions of the USP (43rd edition) and NF (38th edition), as well as the corresponding USP Compounding Compendium, recognizing the importance of several proprietary PCCA bases

Sara Hover discusses the challenges some patients face when it comes to optimizing thyroid hormone levels. She reveals that there are a few, emerging theories that could help patients with thyroid issues.

Melissa Merrell Rhoads and Suki Pramar of PCCA discuss selecting the right antimicrobial preservative when compounding medication for patient health challenges.

Erin Michael discusses how the Pharmacy Technician of today differs wildly from what the position used to be in terms of responsibilities and opportunities, but also how the position has never been more important.

Matt Martin writes to help compounding pharmacies navigate the Food and Drug Administration’s (FDA’s) recently finalized guidance document Insanitary Conditions at Compounding Facilities.